Medicover AB's next confirmed earnings release is scheduled for February 10, 2027.
| Earnings Date | 2/10/2027 |
As of September 30, 2026, Medicover AB has 151.97M shares outstanding.
| Shares Outstanding | 151.97M |
As of September 30, 2026, Medicover AB maintains a current ratio of 0.75, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 226.27, indicating elevated leverage, while an interest coverage ratio of 6.43 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.75 |
| Quick Ratio | 0.08 |
| Debt / Equity | 226.27 |
| Debt / EBITDA | 3.13 |
| Interest Coverage | 6.43 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 58,691.94 in revenue per employee across its workforce of 47,256.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 58,691.94 |
| Employee Count | 47,256.00 |
Over the twelve months ended September 30, 2026, Medicover AB recorded 33.32M in income tax expense. That works out to an effective tax rate of 25.34, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 131.47M, leaving 103.25M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 33.32M |
| Effective Tax Rate | 25.34 |
As of the close on November 2, 2026, Medicover AB's stock has gained approximately 3.67% over the past 52 weeks.
| 52-Week Price Change | 3.67% |
Over the twelve months ended September 30, 2026, Medicover AB generated 2.77B in revenue and converted that into 103.25M in net income, yielding earnings per share of 0.65. EBITDA reached 456.87M, while operating income came in at 206.73M.
| Revenue | 2.77B |
| Gross Profit | 656.47M |
| Operating Income | 206.73M |
| Pretax Income | 131.47M |
| Net Income | 103.25M |
| EBITDA | 456.87M |
| EBIT | 206.73M |
| Earnings Per Share (EPS) | 0.65 |
As of September 30, 2026, Medicover AB holds 97.47M in cash and equivalents against 1.43B in total debt, resulting in a net debt position of 856.96M. Total book value stands at 611.58M, with working capital of -307.15M providing operational flexibility.
| Cash & Cash Equivalents | 97.47M |
| Total Debt | 1.43B |
| Net Debt | 856.96M |
| Equity (Book Value) | 611.58M |
| Book Value Per Share | 4.02 |
| Working Capital | -307.15M |
Medicover AB produced 385.58M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -164.46M in capital expenditures, free cash flow totaled 221.13M - equivalent to 1.46 per share.
| Operating Cash Flow | 385.58M |
| Capital Expenditures | -164.46M |
| Free Cash Flow | 221.13M |
| FCF Per Share | 1.46 |
Over the twelve months ended September 30, 2026, Medicover AB posted a gross margin of 23.67, reflecting its pricing power and cost economics. The operating margin of 7.45 and net profit margin of 3.72 provide insight into operational efficiency.
| Gross Margin | 23.67 |
| Operating Margin | 7.45 |
| Pretax Margin | 4.74 |
| Profit Margin | 3.72 |
| EBITDA Margin | 16.47 |
Over the twelve months ended September 30, 2026, Medicover AB paid dividends of 0.23 per share. The dividend payout ratio of 36.61 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Dividend Per Share | 0.23 |
| Payout Ratio | 36.61 |
Already premium?